
Scientists are still trying to get CAR-T cells to work as well in solid tumors as they do in blood cancers, but the genetically engineered immune cells just might have a superpower beyond oncology. In mice, researchers reported on Wednesday in Nature, CAR-T cells can eliminate the senescent cells partly responsible for many diseases of aging.
If the results hold up, they could add another candidate to a growing list of “senolytics,” experimental drugs that destroy senescent cells. A growing pile of mouse studies show that removing these decrepit and dysfunctional cells postpones or even reverses diseases of old age — and extends life span. The possibility that senolytics could do that in people has jump-started what analysts say could become a multibillion-dollar industry, with clinical trials already underway.
I have extreme heart decease. It was found after 20 years of taking Lipitor I was allergic to statins. I am not able to work and my income is just enough to pay rent and keep food on the table.
Do you have a hardship reduced subscription that is less money that I might subscribe. I’m 66 years okd.
Thank You
Steve Lucore